Evidence map›Paper›PMID 38977784›Full record

ArticleCommunications biology2024

Variants of NAV3, a neuronal morphogenesis protein, cause intellectual disability, developmental delay, and microcephaly.

Amama Ghaffar, Tehmeena Akhter, Petter Strømme, Doriana Misceo, Amjad Khan, Eirik Frengen, Muhammad Umair, Bertrand Isidor, Benjamin Cogné, Asma A Khan and 12 more

Abstract read
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Amama Ghaffar *Department of Otorhinolaryngology-Head & Neck Surgery, School of Medicine University of Maryland, Baltimore, MD, USA.
Tehmeena Akhter *Department of Otorhinolaryngology-Head & Neck Surgery, School of Medicine University of Maryland, Baltimore, MD, USA.ORCID 0009-0003-9691-2097
Petter StrømmeDivision of Pediatric and Adolescent Medicine, Oslo University Hospital and University of Oslo, Oslo, Norway.
Doriana MisceoDepartment of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.
Amjad KhanFaculty of Biological Sciences, Department of Zoology, University of Lakki Marwat, 28420, Khyber, Pakhtunkhwa, Pakistan.
Eirik FrengenDepartment of Medical Genetics, Oslo University Hospital and University of Oslo, Oslo, Norway.ORCID 0000-0002-8387-2247
Muhammad UmairDepartment of Life Sciences, School of Science, University of Management and Technology, Lahore, Pakistan.
Bertrand IsidorNantes Université, CHU Nantes, Service de Génétique Médicale, 44000, Nantes, France.
Benjamin CognéNantes Université, CHU Nantes, Service de Génétique Médicale, 44000, Nantes, France.
Asma A KhanCentre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan.
Ange-Line BruelINSERM UMR1231 GAD "Génétique des Anomalies du Développement", FHU-TRANSLAD, Université de Bourgogne Franche-Comté, Dijon, France.
Arthur SorlinINSERM UMR1231 GAD "Génétique des Anomalies du Développement", FHU-TRANSLAD, Université de Bourgogne Franche-Comté, Dijon, France.
Paul KuentzINSERM UMR1231 GAD "Génétique des Anomalies du Développement", FHU-TRANSLAD, Université de Bourgogne Franche-Comté, Dijon, France.ORCID 0000-0003-2814-6303
Christine ChiaveriniDepartment of Pediatrics, CHU de Nice, Fondation Lenval, Nice, France.
A Micheil InnesDepartment of Medical Genetics, University of Calgary, Calgary, Alberta, Canada.
Michael ZechInstitute of Neurogenomics, Helmholtz Munich, Neuherberg, Germany.
Marek BalážFirst Department of Neurology, Faculty of Medicine, St. Anne's University Hospital, and CEITEC, Masaryk University, Brno, Czech Republic.
Petra HavrankovaDepartment of Neurology, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
Robert JechDepartment of Neurology, Charles University, First Faculty of Medicine and General University Hospital in Prague, Prague, Czech Republic.
Zubair M AhmedDepartment of Otorhinolaryngology-Head & Neck Surgery, School of Medicine University of Maryland, Baltimore, MD, USA.ORCID 0000-0003-2914-4502
Sheikh RiazuddinJinnah Burn and Reconstructive Surgery Centre, Allama Iqbal Medical Research, University of Health Sciences, Lahore, Pakistan.
Saima RiazuddinDepartment of Otorhinolaryngology-Head & Neck Surgery, School of Medicine University of Maryland, Baltimore, MD, USA. sriazuddin@som.umaryland.edu.ORCID 0000-0002-8645-4761

Funding

Genetics and Functional Studies of Autosomal Recessive Neurological DisordersR01NS107428 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI Saima Riazuddin · 2018 to 2026
$4.7M
NINDS NIH HHS R01 NS107428U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) R01NS107428
6 · The paper itself

Abstract

Microtubule associated proteins (MAPs) are widely expressed in the central nervous system, and have established roles in cell proliferation, myelination, neurite formation, axon specification, outgrowth, dendrite, and synapse formation. We report eleven individuals from seven families harboring predicted pathogenic biallelic, de novo, and heterozygous variants in the NAV3 gene, which encodes the microtubule positive tip protein neuron navigator 3 (NAV3). All affected individuals have intellectual disability (ID), microcephaly, skeletal deformities, ocular anomalies, and behavioral issues. In mouse brain, Nav3 is expressed throughout the nervous system, with more prominent signatures in postmitotic, excitatory, inhibiting, and sensory neurons. When overexpressed in HEK293T and COS7 cells, pathogenic variants impaired NAV3 ability to stabilize microtubules. Further, knocking-down nav3 in zebrafish led to severe morphological defects, microcephaly, impaired neuronal growth, and behavioral impairment, which were rescued with co-injection of WT NAV3 mRNA and not by transcripts encoding the pathogenic variants. Our findings establish the role of NAV3 in neurodevelopmental disorders, and reveal its involvement in neuronal morphogenesis, and neuromuscular responses.

Indexed as

Developmental DisabilitiesIntellectual DisabilityMicrocephalyAnimalsChildChild, PreschoolChlorocebus aethiopsCOS CellsFemaleHEK293 CellsHumansMaleMembrane ProteinsMiceMicrotubule-Associated ProteinsNerve Tissue ProteinsMembrane ProteinsMicrotubule-Associated ProteinsNAV3 protein, humanNerve Tissue Proteins

Identifiers

PMID38977784
PMCPMC11231287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.